4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide

C130H120FN15O14S10 — CID 162077540

IUPAC4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide
SMILESCNC(=O)c1ccc([C@@H](C)CC(=O)c2nc(-c3ncc(-c4ccccc4)s3)sc2C2CC2)cc1.C[C@H](CC(=O)c1nc(-c2nc3c(s2)CCCC3)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccc(F)cc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccccc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.Cc1ccc(-c2cnc(-c3nc(C(=O)C[C@@H](C)c4ccc(C(=O)NO)cc4)c(C4CC4)s3)s2)cc1
InChIInChI=1S/C27H25N3O3S2.C27H25N3O2S2.C26H22FN3O3S2.C26H23N3O3S2.C24H25N3O3S2/c1-15-3-5-18(6-4-15)22-14-28-26(34-22)27-29-23(24(35-27)19-9-10-19)21(31)13-16(2)17-7-11-20(12-8-17)25(32)30-33;1-16(17-8-12-20(13-9-17)25(32)28-2)14-21(31)23-24(19-10-11-19)34-27(30-23)26-29-15-22(33-26)18-6-4-3-5-7-18;1-14(15-2-6-18(7-3-15)24(32)30-33)12-20(31)22-23(17-4-5-17)35-26(29-22)25-28-13-21(34-25)16-8-10-19(27)11-9-16;1-15(16-7-11-19(12-8-16)24(31)29-32)13-20(30)22-23(18-9-10-18)34-26(28-22)25-27-14-21(33-25)17-5-3-2-4-6-17;1-13(14-6-10-16(11-7-14)22(29)27-30)12-18(28)20-21(15-8-9-15)32-24(26-20)23-25-17-4-2-3-5-19(17)31-23/h3-8,11-12,14,16,19,33H,9-10,13H2,1-2H3,(H,30,32);3-9,12-13,15-16,19H,10-11,14H2,1-2H3,(H,28,32);2-3,6-11,13-14,17,33H,4-5,12H2,1H3,(H,30,32);2-8,11-12,14-15,18,32H,9-10,13H2,1H3,(H,29,31);6-7,10-11,13,15,30H,2-5,8-9,12H2,1H3,(H,27,29)/t2*16-;14-;15-;13-/m10111/s1
InChIKeyZBXDFYGUPHXSEY-WFRIMZPBSA-N
MW2456.15 g/mol
LogP31.43
Rot. Bonds39

About 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide

4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide (PubChem CID 162077540) has the molecular formula C130H120FN15O14S10 and a molecular weight of 2456.15 g/mol. Its IUPAC name is 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide.

Molecular Properties

Compound Name4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide
PubChem CID162077540
Molecular FormulaC130H120FN15O14S10
Molecular Weight2456.15 g/mol
Exact Mass2453.63
IUPAC Name4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide
SMILESCNC(=O)c1ccc([C@@H](C)CC(=O)c2nc(-c3ncc(-c4ccccc4)s3)sc2C2CC2)cc1.C[C@H](CC(=O)c1nc(-c2nc3c(s2)CCCC3)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccc(F)cc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccccc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.Cc1ccc(-c2cnc(-c3nc(C(=O)C[C@@H](C)c4ccc(C(=O)NO)cc4)c(C4CC4)s3)s2)cc1
InChIInChI=1S/C27H25N3O3S2.C27H25N3O2S2.C26H22FN3O3S2.C26H23N3O3S2.C24H25N3O3S2/c1-15-3-5-18(6-4-15)22-14-28-26(34-22)27-29-23(24(35-27)19-9-10-19)21(31)13-16(2)17-7-11-20(12-8-17)25(32)30-33;1-16(17-8-12-20(13-9-17)25(32)28-2)14-21(31)23-24(19-10-11-19)34-27(30-23)26-29-15-22(33-26)18-6-4-3-5-7-18;1-14(15-2-6-18(7-3-15)24(32)30-33)12-20(31)22-23(17-4-5-17)35-26(29-22)25-28-13-21(34-25)16-8-10-19(27)11-9-16;1-15(16-7-11-19(12-8-16)24(31)29-32)13-20(30)22-23(18-9-10-18)34-26(28-22)25-27-14-21(33-25)17-5-3-2-4-6-17;1-13(14-6-10-16(11-7-14)22(29)27-30)12-18(28)20-21(15-8-9-15)32-24(26-20)23-25-17-4-2-3-5-19(17)31-23/h3-8,11-12,14,16,19,33H,9-10,13H2,1-2H3,(H,30,32);3-9,12-13,15-16,19H,10-11,14H2,1-2H3,(H,28,32);2-3,6-11,13-14,17,33H,4-5,12H2,1H3,(H,30,32);2-8,11-12,14-15,18,32H,9-10,13H2,1H3,(H,29,31);6-7,10-11,13,15,30H,2-5,8-9,12H2,1H3,(H,27,29)/t2*16-;14-;15-;13-/m10111/s1
InChIKeyZBXDFYGUPHXSEY-WFRIMZPBSA-N
XLogP31.43
TPSA440.67 Ų
H-Bond Donors9
H-Bond Acceptors34
Rotatable Bonds39
Heavy Atoms170
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002456.15
LogP ≤ 531.43
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1034

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?
The IUPAC name of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide (CID 162077540) is 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide.
What is the SMILES notation for 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?
The canonical SMILES for 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide is CNC(=O)c1ccc([C@@H](C)CC(=O)c2nc(-c3ncc(-c4ccccc4)s3)sc2C2CC2)cc1.C[C@H](CC(=O)c1nc(-c2nc3c(s2)CCCC3)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccc(F)cc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccccc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.Cc1ccc(-c2cnc(-c3nc(C(=O)C[C@@H](C)c4ccc(C(=O)NO)cc4)c(C4CC4)s3)s2)cc1.
What is the InChIKey of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?
The InChIKey is ZBXDFYGUPHXSEY-WFRIMZPBSA-N. The full InChI is InChI=1S/C27H25N3O3S2.C27H25N3O2S2.C26H22FN3O3S2.C26H23N3O3S2.C24H25N3O3S2/c1-15-3-5-18(6-4-15)22-14-28-26(34-22)27-29-23(24(35-27)19-9-10-19)21(31)13-16(2)17-7-11-20(12-8-17)25(32)30-33;1-16(17-8-12-20(13-9-17)25(32)28-2)14-21(31)23-24(19-10-11-19)34-27(30-23)26-29-15-22(33-26)18-6-4-3-5-7-18;1-14(15-2-6-18(7-3-15)24(32)30-33)12-20(31)22-23(17-4-5-17)35-26(29-22)25-28-13-21(34-25)16-8-10-19(27)11-9-16;1-15(16-7-11-19(12-8-16)24(31)29-32)13-20(30)22-23(18-9-10-18)34-26(28-22)25-27-14-21(33-25)17-5-3-2-4-6-17;1-13(14-6-10-16(11-7-14)22(29)27-30)12-18(28)20-21(15-8-9-15)32-24(26-20)23-25-17-4-2-3-5-19(17)31-23/h3-8,11-12,14,16,19,33H,9-10,13H2,1-2H3,(H,30,32);3-9,12-13,15-16,19H,10-11,14H2,1-2H3,(H,28,32);2-3,6-11,13-14,17,33H,4-5,12H2,1H3,(H,30,32);2-8,11-12,14-15,18,32H,9-10,13H2,1H3,(H,29,31);6-7,10-11,13,15,30H,2-5,8-9,12H2,1H3,(H,27,29)/t2*16-;14-;15-;13-/m10111/s1.
What are the key properties of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?
4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide has a molecular weight of 2456.15 g/mol, XLogP of 31.43, 39 rotatable bonds, 9 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide is sourced from PubChem (CID 162077540), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).